CY1106754T1 - Σκευασματα τιμπολονης - Google Patents

Σκευασματα τιμπολονης

Info

Publication number
CY1106754T1
CY1106754T1 CY20071100984T CY071100984T CY1106754T1 CY 1106754 T1 CY1106754 T1 CY 1106754T1 CY 20071100984 T CY20071100984 T CY 20071100984T CY 071100984 T CY071100984 T CY 071100984T CY 1106754 T1 CY1106754 T1 CY 1106754T1
Authority
CY
Cyprus
Prior art keywords
timbolone
preparation
relates
estren
pregn
Prior art date
Application number
CY20071100984T
Other languages
English (en)
Inventor
Tom Brennan
Austin John Woolfe
Original Assignee
Norton Healthcare Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26246675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1106754(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB0125061.2A external-priority patent/GB0125061D0/en
Application filed by Norton Healthcare Limited filed Critical Norton Healthcare Limited
Publication of CY1106754T1 publication Critical patent/CY1106754T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Ceramic Products (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Powder Metallurgy (AREA)

Abstract

Η εφεύρεση σχετίζεται με το πεδίο των συνθετικών στεροειδών και συγκεκριμένα με οιστρενικά παράγωγα. Ειδικότερα, η εφεύρεση σχετίζεται με σταθεροποιημένες συνθέσεις τιμπολόνης (7α, 17α)-17-υδροξυ-7-μεθυλο-19-νορ-17-πρεγν-5(10)-εν-20-υv-3-όνη, και με μεθόδους παρασκευής των ιδίων.
CY20071100984T 2001-10-18 2007-07-24 Σκευασματα τιμπολονης CY1106754T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0125061.2A GB0125061D0 (en) 2001-10-18 2001-10-18 Pharmaceutical composition
US35012101P 2001-11-02 2001-11-02
PCT/US2002/033526 WO2003032924A2 (en) 2001-10-18 2002-10-18 Novel tibolone formulations

Publications (1)

Publication Number Publication Date
CY1106754T1 true CY1106754T1 (el) 2012-05-23

Family

ID=26246675

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100984T CY1106754T1 (el) 2001-10-18 2007-07-24 Σκευασματα τιμπολονης

Country Status (10)

Country Link
EP (1) EP1444247B1 (el)
AT (1) ATE364619T1 (el)
AU (1) AU2002347973A1 (el)
CY (1) CY1106754T1 (el)
DE (1) DE60220699T2 (el)
DK (1) DK1444247T3 (el)
ES (1) ES2284946T3 (el)
MX (1) MXPA04003588A (el)
PT (1) PT1444247E (el)
WO (1) WO2003032924A2 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05000824A (es) * 2003-05-23 2005-04-28 Akzo Nobel Nv Forma de dosis farmaceutica de liberacion inmediata que contiene tibolona polimorfa.
WO2005084682A1 (en) * 2004-03-08 2005-09-15 Pharmaceutical Services Inc. (Psi Nv.) Pharmaceutical composition comprising cyclodextrin complex of tibolone
WO2005117899A1 (en) * 2004-06-02 2005-12-15 Cipla Limited Pharmaceutical composition comprising tibolone and process for procuding the same
HUE055164T2 (hu) 2016-05-04 2021-11-29 Novalon S A Cukoralkoholok alkalmazása Tobolon tartalmú készítményekben

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
ZA941464B (en) * 1993-03-05 1994-09-27 Akzo Nv Use of pregnane derivative

Also Published As

Publication number Publication date
DK1444247T3 (da) 2007-09-24
EP1444247A4 (en) 2004-12-08
DE60220699T2 (de) 2008-03-06
MXPA04003588A (es) 2005-04-11
EP1444247A2 (en) 2004-08-11
ES2284946T3 (es) 2007-11-16
PT1444247E (pt) 2007-07-09
WO2003032924A2 (en) 2003-04-24
AU2002347973A1 (en) 2003-04-28
WO2003032924A3 (en) 2004-01-29
DE60220699D1 (de) 2007-07-26
ATE364619T1 (de) 2007-07-15
EP1444247B1 (en) 2007-06-13

Similar Documents

Publication Publication Date Title
CY1119742T1 (el) Βιολογικα συστηματα μεταφορας πολλαπλου-συστατικου
CY1105009T1 (el) Συνθεση καχαλαλιδης f
CY1106076T1 (el) Παραγωγα γλυκοπυρανοσυλοξυβενζυλο βενζολιου και ιατρικες συνθεσεις που πepιεχουν τα ιδια
CY1116779T1 (el) Αμιδο ενωσεις και η χρηση τους ως φαρμακευτικες ουσιες
CY1105799T1 (el) Καινουρια προφαρμακα που πepιεχουν φωσφορο
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
ATE368018T1 (de) Gipszusammensetzungen und dazugehörende verfahren
CY1109649T1 (el) Αντιγονα και συνθεσεις απο neisseria
CY1112862T1 (el) Θραυσματα μονοσθενους αντισωματος χρησιμα ως θεραπευτικα
ATE373422T1 (de) Mikroemulsionbildende herbizidkonzentrate, mikroemulsionen und verfahren
DK1353700T3 (da) Præparater af östrogencyclodextrinkomplekser
CY1105225T1 (el) Παραγωγα 5-β-σαπωγενινης και ψευδοσαπωγενινης και η χρηση τους στην αντιμετωπιση ανοιας
CY1112055T1 (el) Συνθεσεις και μεθοδοι για την διαγνωση και θεραπευτικη αγωγη ογκου πνευμονα
CY1109068T1 (el) Υποκατεστημενες πυριδινυλαμινες
HUP0101564A2 (hu) Epotilon készítmények
DE60104206D1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
CY1106682T1 (el) Ενωση λακταμης
CY1106853T1 (el) Χρηση συζευγματων χολικου οξεος ή λιπαρου οξεος χολικου αλατος
CY1105247T1 (el) Υποκατεστημενα παραγωγα c- κυκλοεξυλομεθυλαμινης
CY1106754T1 (el) Σκευασματα τιμπολονης
IS8051A (is) Kladríbínefnablöndur til inngjafar um munn
IS8334A (is) Æxilseyðandi samsetningar sem samanstanda af defíbrótíði stöku eða blönduðu með öðrum æxliseyðandi miðlum
CY1109451T1 (el) 17βητα-ακυλ-17αλφα-προπυνυλ-11βητα-(κυκλικα αμινο)αρυλ στεροειδη και παραγωγα αυτων που εχουν ιδιοτητες ορμονικου ανταγωνιστη
CY1119558T1 (el) Συστημα τοπικης διανομης μικροθρεπτικων συστατικων και χρησεις αυτου
DE50112128D1 (de) Retardpartikeldispersion